Sign in
4/A

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-019622

Director sold 20,000 shares at $57.80 ($1,156,000)

  • Director acquired 20,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Pellini Michael J · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-01 Exercise or conversion : show line 1 in the form +20,000 $6.55 $131,000 21,504 D
2021-03-01 Sale : show line 2 in the form −20,000 $57.80 $1,156,000 1,504 D
Open-market sales · 20,000 sh · avg $57.80 · $1,156,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-03-01 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −20,000 55,000 D
Loading xslF345X03/doc4a.xml…